Related Experiment Video

Updated: Jul 12, 2026

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies

Sofia Duarte1, Francesc Sanmarti, Veronica Gonzalez

  • 1Neurology Department, Hospital Sant Joan de Déu, Barcelona, and Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Spain. sofia.duarte@iol.pt

Brain & Development
|August 24, 2007
PubMed

Insights

Elevated neopterin levels in cerebrospinal fluid may indicate immune activation in infants with early-onset epileptic encephalopathies. This finding is linked to a poorer prognosis and mortality in these devastating neurological conditions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatrics

Background:

  • Early-onset epileptic encephalopathies (EOEEs) are severe infant neurological disorders with poorly understood pathophysiology and limited biomarkers.
  • Identifying biological markers is crucial for understanding EOEEs and improving patient outcomes.

Purpose of the Study:

  • To investigate the relationship between specific types of infantile epileptic encephalopathies and the profile of pterins and neurotransmitters in cerebrospinal fluid (CSF).
  • To explore potential biological markers for prognosis in these conditions.

Main Methods:

  • CSF samples from 23 infants diagnosed with four types of EOEEs were analyzed for biogenic amine metabolites (homovanillic acid, 5-hydroxyindoleacetic acid) and pterins (neopterin, biopterin).
  • Clinical, electroencephalographic, neuroimaging, and follow-up data were collected and analyzed.

Main Results:

  • Seven out of 23 infants exhibited high neopterin levels, with four cases of partial epilepsy with multiple independent spike foci.
  • High neopterin values were significantly associated with increased mortality (chi square = 7.304, p = 0.007).
  • Elevated 5-hydroxyindoleacetic acid was observed in three patients; homovanillic acid levels were mostly normal.

Conclusions:

  • Elevated neopterin levels in CSF suggest central nervous system immune activation in infants with EOEEs.
  • Neopterin may serve as a prognostic biomarker for mortality in these conditions.
  • Further research into CSF profiles could elucidate EOEE pathophysiology.

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...